Dr. Justin Gainor, director of the Middle for Thoracic Cancers Program at Massachusetts Common Hospital, shared steering for sufferers with lung most...
The U.S. Meals and Drug Administration (FDA) has granted breakthrough remedy designation to sofetabart mipitecan for grownup sufferers with platinum-resistant epithelial ovarian,...
The U.S. Meals and Drug Administration (FDA) has accepted Guardant360 CDx as a companion diagnostic to determine sufferers with BRAF V600E-mutant metastatic...
